nitrendipine has been researched along with clotrimazole in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cahalan, MD; Chandy, KG; Grissmer, S; Hansel, W; Miller, MJ; Wulff, H | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Sen, S; Sinha, N | 1 |
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
| Culliford, SJ; Ellory, JC; Mojiminiyi, FB; Stone, PC; Stuart, J | 1 |
| Ahring, PK; Christophersen, P; Hansen, C; Jensen, BS; Jorgensen, TD; Olesen, SP; Silahtaroglu, A; Strobaek, D | 1 |
| Benton, DC; Ganellin, CR; Jenkinson, DH; Roxburgh, CJ; Shiner, MA | 1 |
| Christophersen, P; Jensen, BS; Jorgensen, NK; Odum, N; Olesen, SP | 1 |
11 other study(ies) available for nitrendipine and clotrimazole
| Article | Year |
|---|---|
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant.
Topics: Calcium Channel Blockers; Calcium Channels; Clotrimazole; Cyclosporine; Cytochrome P-450 Enzyme System; Drug Design; Drug Interactions; Electric Conductivity; Humans; Immunosuppressive Agents; Intermediate-Conductance Calcium-Activated Potassium Channels; Ion Channel Gating; Ionomycin; Lymphocyte Activation; Potassium Channels; Pyrazoles; Structure-Activity Relationship; T-Lymphocytes; Tetradecanoylphorbol Acetate | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
Additive in vitro effects of anti-sickling drugs.
Topics: Anemia, Sickle Cell; Antisickling Agents; Benzaldehydes; Calcium; Cells, Cultured; Clotrimazole; Drug Synergism; Erythrocyte Deformability; Erythrocyte Indices; Erythrocytes; Hemorheology; Humans; Nitrendipine; Oxidation-Reduction; Potassium; Potassium Channels; Verapamil | 1994 |
Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel.
Topics: Azepines; Benzimidazoles; Calcium; Cell Line; Charybdotoxin; Chromosome Mapping; Chromosomes, Human, Pair 19; Cloning, Molecular; Clotrimazole; Cnidarian Venoms; Humans; In Situ Hybridization, Fluorescence; Intermediate-Conductance Calcium-Activated Potassium Channels; Ketoconazole; Kidney; Membrane Potentials; Miconazole; Neurotoxins; Nitrendipine; Organ Specificity; Potassium Channels; Potassium Channels, Calcium-Activated; Recombinant Proteins; Scorpion Venoms; Transfection | 1998 |
Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells.
Topics: Analgesics, Non-Narcotic; Animals; Antisickling Agents; Azepines; Calcimycin; Calcium; Calcium Channel Blockers; Cell Membrane Permeability; Charybdotoxin; Clotrimazole; Dose-Response Relationship, Drug; Erythrocyte Membrane; Erythrocytes; Growth Inhibitors; Ionophores; Lead; Mammals; Nitrendipine; Potassium; Potassium Channel Blockers; Quinine; Rabbits; Time Factors | 1999 |
Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels.
Topics: Calcium; Calcium Channel Blockers; Cells, Cultured; Clotrimazole; Concanavalin A; Cyclosporine; Dose-Response Relationship, Drug; Electrochemistry; Enzyme Inhibitors; Growth Inhibitors; Humans; Interferon-gamma; Ketoconazole; Lymphocyte Activation; Nitrendipine; Patch-Clamp Techniques; Phytohemagglutinins; Potassium Channel Blockers; Potassium Channels; T-Lymphocytes; Tetanus Toxin; Time Factors | 1999 |